Development of Selective Covalent Janus Kinase 3 Inhibitors

Journal of Medicinal Chemistry - United States
doi 10.1021/acs.jmedchem.5b00710
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Janus Kinase-3 (JAK-3)

Science-Business eXchange
2011English

Janus Kinase Inhibitors for Autoimmune Disorders

Prescriber
Pharmacology
2017English

Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors

English

Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2013English

Role of Janus Kinase Inhibitors in the Treatment of Alopecia Areata

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Clinical Development of Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin Lymphoma

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2013English

Prolonged and Tunable Residence Time Using Reversible Covalent Kinase Inhibitors

Nature Chemical Biology
Cell BiologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy